Matches in Wikidata for { <http://www.wikidata.org/entity/Q38079893> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q38079893 description "article científic" @default.
- Q38079893 description "article scientifique" @default.
- Q38079893 description "articol științific" @default.
- Q38079893 description "articolo scientifico" @default.
- Q38079893 description "artigo científico" @default.
- Q38079893 description "artigo científico" @default.
- Q38079893 description "artigo científico" @default.
- Q38079893 description "artikel ilmiah" @default.
- Q38079893 description "artikull shkencor" @default.
- Q38079893 description "artículo científico" @default.
- Q38079893 description "artículu científicu espublizáu en 2013" @default.
- Q38079893 description "bilimsel makale" @default.
- Q38079893 description "scienca artikolo" @default.
- Q38079893 description "scientific article published on 04 February 2013" @default.
- Q38079893 description "scientific article published on 04 February 2013" @default.
- Q38079893 description "scientific article published on 04 February 2013" @default.
- Q38079893 description "vedecký článok" @default.
- Q38079893 description "vetenskaplig artikel" @default.
- Q38079893 description "videnskabelig artikel" @default.
- Q38079893 description "vitenskapelig artikkel" @default.
- Q38079893 description "vitskapeleg artikkel" @default.
- Q38079893 description "vědecký článek" @default.
- Q38079893 description "wetenschappelijk artikel" @default.
- Q38079893 description "wissenschaftlicher Artikel" @default.
- Q38079893 description "наукова стаття, опублікована в лютому 2013" @default.
- Q38079893 description "научная статья" @default.
- Q38079893 description "научни чланак" @default.
- Q38079893 description "מאמר מדעי" @default.
- Q38079893 description "مقالة علمية نشرت في 04 فبراير 2013" @default.
- Q38079893 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38079893 name "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 name "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 type Item @default.
- Q38079893 label "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 label "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 prefLabel "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 prefLabel "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 P1433 Q38079893-701BD118-B003-4636-B3F2-A69659704779 @default.
- Q38079893 P1476 Q38079893-A834EABB-E5C4-4505-9A8E-0E02227289AE @default.
- Q38079893 P2093 Q38079893-B92BFD52-B1C7-438E-80F6-09B691BC8EF7 @default.
- Q38079893 P2093 Q38079893-F1F3BBE6-9DA4-4FAB-AC08-3E08274FBE13 @default.
- Q38079893 P304 Q38079893-82A332DF-9C37-49FE-B4A7-690B88209F7E @default.
- Q38079893 P31 Q38079893-358B6C38-15F7-4CDE-89AE-868DC899E9EC @default.
- Q38079893 P356 Q38079893-25D5C4D5-DBFE-4B5B-9BF2-DC8A6D6CCD6C @default.
- Q38079893 P407 Q38079893-887CB84D-BC9A-4376-8B34-AB9001F69D18 @default.
- Q38079893 P433 Q38079893-02271EF8-9C5F-4ABD-8481-93316A809FBE @default.
- Q38079893 P478 Q38079893-DB60129D-65D8-4E8E-9162-8B92EB24CB79 @default.
- Q38079893 P577 Q38079893-76B2B618-7132-4890-9C45-5A0134417306 @default.
- Q38079893 P5875 Q38079893-3EA344ED-AA30-4FE9-8859-075F667A59F2 @default.
- Q38079893 P698 Q38079893-4422420C-98DE-4F77-AF68-F1260C25D816 @default.
- Q38079893 P8608 Q38079893-D66B7616-6F89-4331-B604-EAFB24B7D9C6 @default.
- Q38079893 P921 Q38079893-278E941B-EA14-450B-BD0D-9CE8A46342DD @default.
- Q38079893 P921 Q38079893-38A47EC3-58D3-4E00-BF89-62AEA5306C78 @default.
- Q38079893 P921 Q38079893-A6A2788F-E80A-408C-8C8C-648AE733DF3D @default.
- Q38079893 P921 Q38079893-C01E3A13-616B-475F-A9DC-B6BFFD592E86 @default.
- Q38079893 P356 J.LEUKRES.2013.01.006 @default.
- Q38079893 P698 23391518 @default.
- Q38079893 P1433 Q15716445 @default.
- Q38079893 P1476 "Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib" @default.
- Q38079893 P2093 "Alfonso Quintás-Cardama" @default.
- Q38079893 P2093 "Elias J Jabbour" @default.
- Q38079893 P304 "487-495" @default.
- Q38079893 P31 Q13442814 @default.
- Q38079893 P356 "10.1016/J.LEUKRES.2013.01.006" @default.
- Q38079893 P407 Q1860 @default.
- Q38079893 P433 "5" @default.
- Q38079893 P478 "37" @default.
- Q38079893 P577 "2013-02-04T00:00:00Z" @default.
- Q38079893 P5875 "235421559" @default.
- Q38079893 P698 "23391518" @default.
- Q38079893 P8608 "release_kcqgupx3a5gabohw6oadk5stly" @default.
- Q38079893 P921 Q11688946 @default.
- Q38079893 P921 Q27139135 @default.
- Q38079893 P921 Q419940 @default.
- Q38079893 P921 Q729735 @default.